Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses ———— — Research & development ———— — Operating income -84.61 K-71.19 K-172.86 K-137.66 K -466.32 K Non-Operating Income, Total ———— — Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses ———— — Unusual income/expense ———— — Pretax income -84.61 K-71.19 K-172.86 K-137.66 K -466.32 K Equity in earnings ———— — Taxes 0000 0 Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 113.31 K566.44 K383.81 K371.7 K 1.44 M Discontinued operations ———— — Net income 113.31 K566.44 K383.81 K371.7 K 1.44 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 113.31 K566.44 K383.81 K371.7 K 1.44 M Basic earnings per share (Basic EPS) ———— — Diluted earnings per share (Diluted EPS) ———— — Average basic shares outstanding ———— — Diluted shares outstanding ———— — EBITDA ———— — EBIT 119.21 K510.94 K376.95 K365.81 K 1.37 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —